Frontage Laboratories (Shanghai) Co. Ltd. agreed to acquire remaining 25% stake in Frontage Laboratories (Suzhou) Co.,Ltd. from Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) for CNY 19.6 million on September 9, 2024. Upon completion, Frontage Laboratories (Shanghai) Co. Ltd. will own 100% stake in Frontage Laboratories (Suzhou) Co.,Ltd. As of June 30, 2024, Frontage Laboratories (Suzhou) Co.,Ltd. reported total assets of CNY 48.55 million and total common equity of CNY 29.7 million.